MILLENNIUM PHARMACEUTICALS INC
10-Q, EX-27, 2000-07-26
PHARMACEUTICAL PREPARATIONS
Previous: MILLENNIUM PHARMACEUTICALS INC, 10-Q, EX-10.5, 2000-07-26
Next: MILLENNIUM PHARMACEUTICALS INC, 10-Q, EX-99.1, 2000-07-26



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         154,865
<SECURITIES>                                   489,885
<RECEIVABLES>                                   18,919
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               676,848
<PP&E>                                         120,112
<DEPRECIATION>                                (51,635)
<TOTAL-ASSETS>                                 938,350
<CURRENT-LIABILITIES>                           79,806
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            94
<OTHER-SE>                                     430,397
<TOTAL-LIABILITY-AND-EQUITY>                   938,350
<SALES>                                              0
<TOTAL-REVENUES>                                93,646
<CGS>                                                0
<TOTAL-COSTS>                                  168,122
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              12,135
<INCOME-PRETAX>                               (68,813)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (68,813)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (68,813)
<EPS-BASIC>                                     (1.25)
<EPS-DILUTED>                                   (1.25)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission